These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 35944492

  • 1. Botulinum Toxin as an Effective Treatment for Trigeminal Neuralgia in Surgical Practices.
    Tangney T, Heydari ES, Sheldon BL, Shetty A, Argoff CE, Khazen O, Pilitsis JG.
    Stereotact Funct Neurosurg; 2022; 100(5-6):314-320. PubMed ID: 35944492
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
    Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, Xia L, Han Q, Zhao Y.
    Brain Behav; 2019 Oct; 9(10):e01409. PubMed ID: 31541518
    [Abstract] [Full Text] [Related]

  • 3. Patterns of opioid use in patients with trigeminal neuralgia undergoing neurosurgery.
    Yang AI, McShane BJ, Hitti FL, Sandhu SK, Chen HI, Lee JYK.
    J Neurosurg; 2019 Dec 01; 131(6):1805-1811. PubMed ID: 30641832
    [Abstract] [Full Text] [Related]

  • 4. Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA.
    Asan F, Gündüz A, Tütüncü M, Uygunoğlu U, Savrun FK, Saip S, Siva A.
    Headache; 2022 Nov 01; 62(10):1322-1328. PubMed ID: 36437599
    [Abstract] [Full Text] [Related]

  • 5. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
    Tereshko Y, Valente M, Belgrado E, Dalla Torre C, Dal Bello S, Merlino G, Gigli GL, Lettieri C.
    Toxins (Basel); 2023 Nov 14; 15(11):. PubMed ID: 37999517
    [Abstract] [Full Text] [Related]

  • 6. Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia.
    Lunde HM, Torkildsen Ø, Bø L, Bertelsen AK.
    Headache; 2016 Jun 14; 56(6):1035-9. PubMed ID: 26992044
    [Abstract] [Full Text] [Related]

  • 7. Compared to oxcarbazepine and carbamazepine, botulinum toxin type A is a useful therapeutic option for trigeminal neuralgia symptoms: A systematic review.
    Naderi Y, Rad M, Sadatmoosavi A, Khaleghi E, Khorrami Z, Chamani G, Shabani M.
    Clin Exp Dent Res; 2024 Apr 14; 10(2):e882. PubMed ID: 38558383
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia?
    Shehata HS, El-Tamawy MS, Shalaby NM, Ramzy G.
    J Headache Pain; 2013 Nov 19; 14(1):92. PubMed ID: 24251833
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.
    Cephalalgia; 2012 Apr 19; 32(6):443-50. PubMed ID: 22492424
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Trigeminal Neuralgia: An Update on Systematic Review With Meta-analyses.
    Hu X, Xia Y, Li J, Wang X, Liu H, Hu J, Bi J, Wu J, Wang T, Lin Z, Xiong N.
    Clin J Pain; 2024 Jun 01; 40(6):383-392. PubMed ID: 38385501
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy and safety of Botulinum Toxin A Therapy in Trigeminal Neuralgia: a systematic review and meta-analysis of randomized controlled trials.
    Morra ME, Elgebaly A, Elmaraezy A, Khalil AM, Altibi AM, Vu TL, Mostafa MR, Huy NT, Hirayama K.
    J Headache Pain; 2016 Dec 01; 17(1):63. PubMed ID: 27377706
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Botulinum Toxin Type A in Trigeminal Neuralgia in a South Asian Cohort.
    Caldera MC, Senanayake SJ, Perera SP, Perera NN, Gamage R, Gooneratne IK.
    J Neurosci Rural Pract; 2018 Dec 01; 9(1):100-105. PubMed ID: 29456352
    [Abstract] [Full Text] [Related]

  • 13. CGRP Plasma Levels Decrease in Classical Trigeminal Neuralgia Patients Treated with Botulinum Toxin Type A: A Pilot Study.
    Zhang Y, Lian Y, Zhang H, Xie N, Chen Y.
    Pain Med; 2020 Aug 01; 21(8):1611-1615. PubMed ID: 32167549
    [Abstract] [Full Text] [Related]

  • 14. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report.
    Bohluli B, Motamedi MH, Bagheri SC, Bayat M, Lassemi E, Navi F, Moharamnejad N.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan 01; 111(1):47-50. PubMed ID: 20674409
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effect of Botulinum toxin-A in 88 patients with trigeminal neuralgia with 14-month follow-up.
    Li S, Lian YJ, Chen Y, Zhang HF, Ma YQ, He CH, Wu CJ, Xie NC, Zheng YK, Zhang Y.
    J Headache Pain; 2014 Jun 22; 15(1):43. PubMed ID: 24952600
    [Abstract] [Full Text] [Related]

  • 16. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
    Zhang H, Lian Y, Ma Y, Chen Y, He C, Xie N, Wu C.
    J Headache Pain; 2014 Sep 27; 15(1):65. PubMed ID: 25263254
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
    Hu Y, Guan X, Fan L, Li M, Liao Y, Nie Z, Jin L.
    J Headache Pain; 2013 Aug 21; 14(1):72. PubMed ID: 23964790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.